Cargando…
Targeted Toxins for the Treatment of Prostate Cancer
Prostate cancer is the second most common cancer and the fifth leading cause of cancer deaths worldwide. Despite improvements in diagnosis and treatment, new treatment options are urgently needed for advanced stages of the disease. Targeted toxins are chemical conjugates or fully recombinant protein...
Autor principal: | Wolf, Philipp |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391386/ https://www.ncbi.nlm.nih.gov/pubmed/34440190 http://dx.doi.org/10.3390/biomedicines9080986 |
Ejemplares similares
-
Pseudomonas Exotoxin A Based Toxins Targeting Epidermal Growth Factor Receptor for the Treatment of Prostate Cancer
por: Fischer, Alexandra, et al.
Publicado: (2020) -
Synergistic Cytotoxicity of a Toxin Targeting the Epidermal Growth Factor Receptor and the Glycosylated Triterpenoid SO1861 in Prostate Cancer
por: Fischer, Alexandra, et al.
Publicado: (2023) -
Treatment of metastatic prostate cancer after STAMPEDE
por: Wolf, Philipp
Publicado: (2017) -
BH3 Mimetics for the Treatment of Prostate Cancer
por: Wolf, Philipp
Publicado: (2017) -
Prostate Cancer Stem Cells: Clinical Aspects and Targeted Therapies
por: Wolf, Isis, et al.
Publicado: (2022)